CV Sciences, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
CV Sciences, Inc. (CVSI) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $0.04 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-08-13
- CV Sciences, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2026-03-31 was $0.04, a 0.00% change year-over-year.
- CV Sciences, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2025-03-31 was $0.04.
- CV Sciences, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- CV Sciences, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-03-31 was $0.04.
- CV Sciences, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2025 was $0.04, a 20.00% decline from fiscal 2024.
- CV Sciences, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $0.05, a 25.00% increase from fiscal 2023.
- CV Sciences, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $0.04.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.04 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | $0.04 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | $0.04 10-K · filed 2026-03-26 | |||
| 2025-09-30 | $0.04 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | $0.04 10-Q · filed 2025-08-13 | |||
| 2025-03-31 | $0.04 10-Q · filed 2025-05-14 | |||
| 2024-12-31 | $0.05 10-K · filed 2025-03-27 | |||
| 2024-09-30 | $0.05 10-Q · filed 2024-11-14 | |||
| 2024-06-30 | $0.05 10-Q · filed 2024-08-13 | |||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-15 | |||
| 2023-12-31 | $0.04 10-K · filed 2024-03-29 | |||
| 2023-09-30 | $0.05 10-Q · filed 2023-11-14 | |||
| 2023-06-30 | $0.05 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | $0.04 10-Q · filed 2023-05-15 |